Savolitinib Plus Osimertinib in Epidermal Growth Factor Receptor-Mutated, MET-Amplified Advanced Non-Small Cell Lung Cancer: A Randomized Phase II trial

作者：James Chih‐Hsin Yang, Yuh‐Min Chen, Ullas Batra, Kien Hung, Piyada Sitthideatphaiboon, Pongwut Danchaivijitr, Kang-Yun Lee, Jarin Chindaprasirt, Cheng‐Ta Yang, G.-C. Chang, Chaiyut Charoentum, Teerapat Ungtrakul, Juan Ignacio Hernández Morán, Ryan J. Hartmaier, I. Igwegbe, Alexander Gont, Matthew Haskins, Wanning Xu, Jonathan W. Riess · 发表于：Clinical Lung Cancer · 年份：2025 · DOI：10.1016/j.cllc.2025.10.018 · 被引用次数：3 · 研究领域：Lung Cancer Treatments and Mutations、Fibroblast Growth Factor Research、Lung Cancer Diagnosis and Treatment